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Autophagy is a constitutive, catabolic process leading to the lysosomal degradation of
cytosolic proteins and organelles. However, it is also induced under stress conditions,
remodeling the eukaryotic cell by regulating energy, protein, and lipid homeostasis. It is
likely that the autophagosomal/lysosomal pathway evolved primordially to recycle cell com-
ponents, but further functionally developed as to become part of the immune system to
defend against invading pathogens. Likewise, pathogenic, foreign agents developed strate-
gies to ﬁght back and even to employ the autophagymachinery to their own beneﬁt. Hence,
the regulation of autophagy has many implications on human health and disease. This
review summarizes the molecular dynamics of autophagosome formation, maturation, and
target selection. Membrane dynamics, as well as protein–protein and protein–membrane
interactions are particularly addressed. In addition, it recapitulates current knowledge of
the inﬂuences of inﬂuenza virus infection on the process.
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SO IT BEGINS
Autophagy comprises several diverse lysosomal degradation path-
ways. Chaperone-mediated autophagy involves the direct translo-
cation of cytosolic proteins across the lysosomal membrane (Dice,
2007). During microautophagy the lysosomal membrane invagi-
nates or protrudes to sequester and deliver portions of cytoplasm
directly into lysosomes (Klionsky et al., 2007). Macroautophagy,
hereafter referred to as autophagy, is a lysosomal degradation
pathway mediated by specialized organelles, autophagosomes, and
will be the focus of this review. Autophagosomes enclose part
of the cytoplasm destined for recycling. The exact mechanism
of autophagosome formation remains still unknown. However,
growing evidence suggests that a subdomain of the endoplasmic
reticulum (ER) is crucial for autophagosome biogenesis (Hayashi-
Nishino et al., 2009, 2010; Ylä-Anttila et al., 2009). Particularly, it
has been observed by electron microscopy that ER cisternae often
associate with early autophagic structures (Hayashi-Nishino et al.,
2010). Nevertheless, the origin of the autophagosomal membrane
and how it is formed is still under debate (Chen and Klionsky,
2011). Next to the ER, mitochondria (Hailey et al., 2010), and the
plasma membrane (Ravikumar et al., 2010) have been discussed
as membrane sources. Almost two decades ago, complementa-
tion screening of yeast genes allowed identiﬁcation of minimally
15 genes responsible for autophagosome formation (Tsukada and
Ohsumi, 1993). Lately this list has grown to 33 entries of which
17 are required for all autophagy subtypes (Inoue and Klionsky,
2010). These genes are named ATG (autophagy-related) and their
orthologs are essentially conserved in all eukaryotes (Noda et al.,
2009). In this work,Atg refers to autophagy genes in yeast andATG
is reserved for their mammalian orthologs.
Although autophagy is a constitutive process, it can also be
induced by different stress conditions, e.g., amino acid starva-
tion or growth factor deprivation (Figure 1A). These treatments
induce autophagy through the inhibition of the mammalian tar-
get of rapamycin (mTOR), a serine–threonine kinase central in
autophagy regulation. mTOR exists as part of at least two com-
plexes: complex 1 (mTORC1) is sensitive to nutrient abundance
and is made-up of mTOR along with the subunits Raptor, mLST8
(also known as G protein beta subunit-like) and PRAS40. When
activated, mTORC1 stimulates cell growth by promoting protein
translation and ribosome synthesis,while it inhibits cellular degra-
dation by autophagy (Chan, 2009). mTORC2, containing Rictor,
mSin1, mLST8, and Protor next to mTOR, is discussed as acting
on the cytoskeleton through other kinases, such as the serine–
threonine kinase Akt and SGK1 kinase (Chan, 2009; Kim and
Guan, 2011; Zoncu et al., 2011). InDrosophilamelanogaster a third
TOR complex was identiﬁed, dTTT (Drosophila TOR, TELO2,
TTI1) which is required for dTORC1/dTORC2 activity and cell
growth (Glatter et al., 2011).
It is known from yeasts, that inhibition of TORC1 by
rapamycin, starvation, or other stresses induces formation of an
activated Atg1 complex along with the cofactors Atg13 and Atg17,
both needed for maximal Atg1 catalytic activity (Mizushima,
2010). The Atg1–Atg13–Atg17 complex has serine–threonine
kinase activity and its formation leads to autophagy induction.
In contrast, when TORC1 is active, it leads to Atg13 phosphory-
lation and subsequent destabilization of the complex and effec-
tive Atg1 inactivation (Chan, 2009). It remains unclear, how-
ever, whether TOR directly phosphorylates Atg13 (Mizushima,
2010).
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FIGURE 1 | Autophagosome formation and underlying signaling
events. (A) Autophagy is a cellular stress response that can be induced
inter alia by nutrition and growth factor deprivation. Active mTORC1 inhibits
autophagosome generation, whereas active ULK- and VPS34 class III
PI3K-complexes are prerequisites for autophagosome formation. The
phagophore enraptures cytoplasm and matures to an autophagosome, also
fusing with endosomes. Acidic hydrolases degrade the constituents in
autolysosomes enabling a recycling of bio-molecules (green: stimulatory
signals; pink: inhibitory signals; ﬁgure not complete). (B) Under growth
conditions mTOR is active inhibiting the ULK-complex and by this
autophagy. (C) Under starvation conditions mTOR is inactive and ULK
active, phosphorylating itself and its binding partners and translocating to
pre-autophagosomal structures.
The functional counterparts to this complex in mammals are
ULKs, ATG13 and FIP200 (orthologs of Atg1, Atg13, and Atg17,
respectively). ULK1 is the best characterized Atg1 homolog. The
role of the other isoforms ULK2 and ULK3 in autophagy are yet
less clear. Although it seems likely thatULK2 is partially redundant
to ULK1 (Chan, 2009), ULK3 may not have equivalent functions
(Mizushima, 2010). Under non-stress conditions, mTORC1
associates with the ULK1–ATG13–FIP200–ATG101 complex by
a direct interaction between Raptor and ULK1 (Chan, 2009;
Mizushima, 2010), and phosphorylates ULK1 andATG13, inhibit-
ing their activity (Figure 1B). On the other hand, when mTORC1
is inactive, it dissociates from the ULK1 complex, leading to ULK1
activation. In its active state, ULK1 undergoes autophosphoryla-
tion and phosphorylates ATG13 and FIP200 (Figure 1C). ULK1,
ATG13,FIP200, andATG101 accomplish their function by translo-
cating from the cytosol to subdomains of the ER, and are thus
essential for initiation of autophagosome formation (Mizushima,
2010). These proteins lead to the isolation of membrane subdo-
mains by recruitment of a class III phosphatidylinositol-3-OH
kinase (PI3K) complex to the ER. The PI3K complex includes
VPS34 (also known as PIK3C3), VPS15 (PIK3R4 and p150),
Beclin-1 (ATG6), ATG14, and AMBRA1 (Levine et al., 2011). At
this point of autophagy induction, not only protein components
have decisive functions in autophagosome formation, also the
role of lipids is crucial in its regulation. In the following section,
we focus on the hinge role of lipids within protein dynamics in
autophagy.
THE LIPID CONNECTION
Phosphatidylinositols (PI) are negatively charged phospholipids
present as minor component at the cytosolic side of eukaryotic cell
membranes (Leevers et al., 1999). PI can be phosphorylated on its
inositol ring to form PI-phosphate (PIP), PI-bisphosphate (PIP2),
and PI-trisphosphate (PIP3; Burman and Ktistakis, 2010). PIP,
PIP2, and PIP3 are collectively called phosphoinositides (Leevers
et al., 1999).
In general, PI3Ks are responsible for phosphorylating the
3′OH-position of the inositol ring of PI, yielding PI3P (Bur-
man and Ktistakis, 2010). Synthesis of PI3P is a strictly necessary
requirement for all organisms undergoing autophagy (Burman
and Ktistakis, 2010). The function of PI3P is to gather signaling
proteins containing speciﬁc lipid-binding domains to the mem-
brane. Particularly in autophagy, such effectors are the double
FYVE-containing protein 1 (DFCP1) and WD40-repeat domain
phosphoinositide-interacting (WIPI, homolog to Atg18 in yeast)
family proteins (Levine et al., 2011). DFCP1, in contrast to most
FYVE domain proteins that localize to endosomes, is located
mainly at the ER, where PI3P is usually absent until autophagy
is induced (Noda et al., 2010). Then, DFCP1 translocates to the
autophagosome formation site, drawn by PI3P, to produce ER-
associatedΩ-like structures called omegasomes (Axe et al., 2008).
The other effector of PI3P during autophagy, WIPI/Atg18, func-
tions downstream of DFCP1 and was suggested to help the devel-
opment of omegasomes into autophagosomes.WIPI2 is the major
isoform among the four WIPI isoforms in most mammalian cells
(Polson et al., 2010).
The FYVE domain is named after the four proteins in which it
has been found: Fab1p (yeast ortholog of PIKfyve), YOTB, Vac1p
(vesicle transport protein), and EEA1 (early endosome antigen
1). It is characterized by having two zinc ions and eight poten-
tial zinc coordinating cysteine residues. Additionally, several basic
amino acids are localized around the cysteines. FYVE domains are
part of cysteine-rich proteins, which bind PI3P in a way depen-
dent on their metal ion coordination and interaction of their basic
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amino acids with the negative charged PI3P head group (Krauss
and Haucke, 2007). Figure 2A shows the tertiary structure of a
FYVE domain and the coordination mode of the two metal ions to
the eight cysteine residues. Figure 2B shows EEA1 and its binding
mode to inositol-1,3-diphosphate, as a representative example of
their interaction. It has been suggested that the binding causes con-
formational changes regulating protein–protein or lipid–protein
interactions (Leevers et al., 1999). Most pathways regulated by
PI, including autophagy, depend on their generation and like-
wise on their consumption. A situation where PI persist longer
than the lipid signal is needed will result in loss of homeostasis.
Jumpy is a PI3P phosphatase, which inhibits recruitment of WIPI
to the autophagic membranes, and thus is in charge of PI3P signal
termination (Vergne et al., 2009).
Independently of the conditions triggering the catabolic path-
way, autophagy begins with activation of the class III PI3K
Beclin-1-complex in mammals, necessary to target membranes
for autophagosome generation and posterior maturation. Beclin-
1, homolog of yeast Atg6, will be treated in detail below as target
of various viruses to abort autophagy and to use the autophagy
machinery for their own infectious purposes.
ONE WAY TICKET TO THE AUTOPHAGOSOME
Two ubiquitin-like conjugation systems (UBL), ATG12, and LC3,
have been implicated in biogenesis and membrane expansion of
autophagosomes (Münz, 2011a; Weidberg et al., 2011a). Modiﬁ-
cation of proteins with ubiquitin-like proteins follows a similar
mechanism like modiﬁcation with ubiquitin itself. For this rea-
son, it is worthwhile to brieﬂy summarize the general process
(Figure 3A): Ubiquitin is a 76 amino acid-residue polypeptide,
whose role is to direct proteins to the proteasome for degradation,
among other regulatory functions. Ubiquitin is activated by an E1
enzyme and, subsequently, E2 enzymes pick up activated ubiquitin
by transthiolation and together with E3 enzymes catalyze ubiquiti-
nation of substrates. E3 enzymes function to recognize substrates
and are also capable of interacting with E2, allowing conjuga-
tion of ubiquitin to target proteins. There are two major types
of E3 enzymes in eukaryotes, deﬁned by the presence of either a
HECT or a RING domain (Deshaies and Joazeiro, 2009). HECT
and RING E3s catalyze ubiquitin transfer by different mechanisms
(Figure 3A). HECT-domain containing E3s bind themselves ubiq-
uitin from an E2 protein before transferring it to its target protein.
RING E3s function as a bridge between an activated E2 and a
target protein. Ubiquitination can be a repetitive process leading
to the generation of polyubiquitin chains or multiple mono-
ubiquitinations. It is also a dynamic process. Deubiquitinating
enzymes are able to trim polyubiquitin chains or to remove single
moieties allowing their recycling. Although eukaryotic cells have
only one or few E1 enzymes, they encode more than 40 isoforms
of E2 and more than 600 E3 enzymes (Grabbe et al., 2011). As
it is to be expected, the number of E2 and E3 isoforms show a
higher degree of complexity of the ubiquitin conjugation systems
in human cells relative to yeast (Hicke et al., 2005), enabling to rec-
ognize diverse proteins in a highly speciﬁc manner (Hochstrasser,
2009).
Figure 3B shows the two UBL systems operating in autophagy.
Firstly, the ATG12–ATG5 conjugation is generated by ATG7 (E1-
like) and ATG10 (E2-like). ATG12–ATG5 bind to ATG16L1 and
promote autophagosome formation (Fujita et al., 2008a;Weidberg
et al., 2011a). It has been shown in yeast, that it is the Atg12–
Atg5 complex itself that catalyzes the transfer of Atg8 from Atg3
to the substrate, phosphatidylethanolamine (PE), thus, behav-
ing as a ubiquitin–protein ligase E3-like enzyme (Hanada et al.,
2007). Secondly, LC3s, mammalian Atg8 homologs, are synthe-
sized as precursors with an extra sequence at the C-terminus,
which must be cleaved by the protease ATG4, resulting in the
LC3 form I (LC3-I; Mizushima et al., 2011). LC3-I is then readily
conjugated to PE (forming LC3-II). PE is a lipid found in bio-
logical membranes and lipidation of LC3/Atg8 during autophagy
anchors this protein to the autophagosomal membrane. LC3/Atg8
may serve different purposes. Yeast Atg8 has been shown to
be important for phagophore membrane elongation (Abeliovich
et al., 2000). In addition, LC3/Atg8 functions as a membrane
anchor enabling the targeting of substrates to the autophago-
some (Münz, 2011a). It was also shown that it is important
for membrane tethering and fusion (Nakatogawa et al., 2007;
Weidberg et al., 2011b). However, these studies were performed
in vitro and in a recent in vivo study it was suggested that
soluble NSF attachment protein receptor (SNARE) proteins are
required for membrane fusion, given that Atg8 is not able to
FIGURE 2 | (A) Structure of protein FYVE domain of the RUN and FYVE
domain containing protein 1; Zn atoms are shown in red and coordinating
cysteins in yellow (PDB code 2yw8). (B) Homodimer of EEA1’s
C-terminal FYVE domain bound to inositol-1,3-diphosphate (PDB code
1joc). The picture was prepared using the program VMD (Humphrey
et al., 1996).
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FIGURE 3 | Ubiquitin and ubiquitin-like conjugation systems. (A)The
ubiquitination system. E1–E2–E3 enzymatic cascades are depicted. (B)The
whole set of ubiquitin-like reactions taking part in autophagy involves the E1-,
E2-, and E3-like enzymes ATG7, ATG3/ATG10, and ATG12–ATG5/ATG16L1,
respectively. Crystallographic structure of (C) LC3 (PDB code 1ugm), (D)
GABARAP (PDB code 1kjt), (E) GABARAPL2 (PDB code 1eo6), (F) ubiquitin
(PDB code 1aar), and (G) superimposition of ubiquitin (yellow) and LC3
(green) crystallographic structures. MultiProt Server was employed for protein
alignment based on their structures (Shatsky et al., 2004). The picture was
prepared using the program VMD (Humphrey et al., 1996).
mediate membrane fusion under physiological PE levels (Nair
et al., 2011).
Yeast has a single Atg8 protein while mammals have sev-
eral paralogs: three MAP1 light chain three (LC3A, LC3B, and
LC3C) and four gamma-aminobutyrate receptor associated pro-
tein (GABARAP) and GABARAP-like proteins (GABARAPL1-3),
collectively referred to as LC3s. The roles of LC3s remained unclear
for a long time, since the other isoforms partially compensated
the loss of function of a speciﬁc LC3 form in knockout studies
(Noda et al., 2009). Figures 3C–E displays the remarkable struc-
tural similarities of the different LC3 forms among themselves and
to ubiquitin (Figure 3F). Superimposition of LC3 and ubiquitin
structures clearly shows the high resemblance between these two
proteins (Figure 3G).
Anchoring of autophagosomal substrates by LC3/Atg8 is
accomplished by direct interaction with cargo proteins or by adap-
tor proteins. NIX is a mitochondrial membrane protein capable
of interacting with LC3s during mitophagy, the selective removal
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of mitochondria by autophagy (Novak et al., 2010). Examples of
adaptor proteins are p62/sequestosome 1 (Bjorkoy et al., 2005;
Pankiv et al., 2007), optineurin (Wild et al., 2011), NBR1 (Kirkin
et al., 2009), or NDP52 (Thurston et al., 2009), which favor
interaction between LC3/Atg8 and polyubiquitinated substrates
(Figure 4A; Münz, 2011a). p62 and NBR1 differ in size but their
structures share three domains: an N-terminal PB1 domain, a LIR
motif capable of interacting with LC3 proteins, and a C-terminal
UBA domain interacting with ubiquitin. Both cargo proteins, p62
and NBR1, cooperate in the targeting of ubiquitinated proteins to
the autophagosome, and are both required for their degradation
by autophagy (Lamark et al., 2009). The binding is mediated by
the 22 amino acid-residue sequence forming the conserved LIR
motif with the core W/YxxL/I, which is indispensable for LC3
recruitment into p62-positive inclusion bodies (Figures 4B,C;
Pankiv et al., 2007; Shpilka et al., 2011). It could be shown that
phosphorylation of p62’s UBA domain enhances degradation of
polyubiquitinated proteins (Matsumoto et al., 2011).
The next step in the maturation of an autophagosome is its
closure. It is known that a defect in LC3 function leads to unclosed
autophagosomes (Fujita et al., 2008b). The current model sug-
gests that when the autophagosome double membrane is about to
close forming a narrow pore, LC3 molecules, especially GABARAP
proteins,meet and catalyze the mixture of lipids of the pore, form-
ing a stalk. Disintegration of the stalk completes autophagosome
closure (Noda et al., 2009). However, also here a role of SNARE
proteins cannot be ruled out. The completed autophagosome is
then ready to fuse with late endosomes, forming amphisomes
(Gordon and Seglen, 1988), followed by fusion with lysosomes,
resulting in autolysosomes, and its inner membrane and cargo get
degraded by lysosomal hydrolysis (Figure 1A; Münz, 2011a).
Traditionally, autophagy has been described as unselective
bulk degradation (Seglen et al., 1990), however, the discovery
of autophagy receptors like p62 and NBR1 which also shuttle
polyubiquitinated protein aggregates to autophagosomes during
classical autophagy indicates the existence of target recognition
and possibly directed transport. We could show by a global pro-
teomics approach that the subcellular localization of proteins
inﬂuences their degradation dynamics by autophagy (Kristensen
et al., 2008). During 36 h of amino acid starvation cytosolic pro-
teins were initially degraded, only followed at later time points
by organellar proteins, such as ribosomal and mitochondrial
proteins. In a follow-up study we compared the proteomic com-
position of autophagosomes after different autophagy-inducing
stimuli (Dengjel et al., 2012). Theproteomic compositionof stress-
induced autophagosomes during amino acid starvation differed
clearly from autophagosomes induced by rapamycin treatment or
by block of basal autophagy by concanamycinA,an inhibitor of the
lysosomal H+-ATPase. Comparing the proteome of autophago-
somes over time also highlighted quantitative abundance differ-
ences of autophagosomal proteins. Hence, the inducing stimuli, as
well as the time frameof stimulation, seem to inﬂuence the compo-
sition of autophagosomes. If (macro)autophagy is per deﬁnition
unspeciﬁc,wemight have to consider the possibility that only basal
macroautophagy is truly unspeciﬁc and that all variants of stress-
induced (macro)autophagy should instead be regarded as speciﬁc,
similar to organelle-speciﬁc autophagy subtypes. Thus, we might
want to discriminate, e.g., between growth factor- and amino acid-
starvation induced (macro)autophagy. Another possibility might
be that (macro)autophagy per se is not unspeciﬁc and we just
did not succeed to elucidate the underlying signaling events until
now. Modern high-throughput “omics” approaches in combina-
tionwith systems biology allow for generation of large datasets and
construction of mathematical models which may help in shedding
more light on these complex biological processes (Zimmermann
et al., 2010; Engelke et al., 2012).
AUTOPHAGY AND ANTIGEN PROCESSING
Even though autophagy mainly serves as protein degrading mech-
anism, it is likely that the same machinery has been adopted to
participate in adaptive immunity (Levine et al., 2011). Thus, it
could be shown that autophagy can be induced by activation
of innate immune receptors in antigen presenting cells. Conve-
niently, fragments of proteins from infecting pathogens, which are
degraded through autophagy, result in foreign peptides which can
be complexed to MHC molecules and presented to T cells (for
detailed review see Münz, 2011b). Classically, MHC class I mole-
cules were regarded to present peptides from intracellular antigens
to CD8+ T cells. Peptides are generated by proteasomal processing
and translocate to the ER via the transporter for antigenic peptides
where they are loaded to nascent MHC class I complexes with the
help of chaperones. In the cytosol and the ER peptides may be
further processed by additional proteases before binding to MHC
class I chains. Finally, MHC-I-peptide complexes transit to the
FIGURE 4 |Targeting of substrates to the autophagosome. (A) During
autophagy, the autophagosome engulfs the cargo via LC3/Atg8, covalently
bound to PE on both sides of the membranes by two ubiquitin-like
conjugation systems depicted in Figure 3. (B,C) Interaction between human
GABARAPL1 and the LIR motiv of NBR1, displayed in two different
representation forms (PDB code 2l8j).
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cell surface where they can be recognized by CD8+ T cells. An
alternative pathway, called cross-presentation, allows presentation
of peptides from exogenous antigens on MHC class I molecules
(Crotzer and Blum, 2010). Whereas the classical MHC class I
presentation pathway seems not to be inﬂuenced by autophagy,
it could be shown that autophagy modulates MHC class I pre-
sentation during late stage herpes simplex virus (HSV) infection
(English et al., 2009).
Under normal conditions,MHC class IImolecules present pep-
tides on antigen presenting cells to CD4+ T cells, but during
infection or inﬂammation MHC-II expression can be induced in
non-immune cells as well. MHC class II molecules were viewed
to present mainly peptides from extracellular antigens. However,
MHC-II peptide analyses revealed that also peptides from intra-
cellular source proteins are presented on MHC class II molecules.
MHC class II α and β chains are synthesized into the ER and the
chaperone invariant chain (Ii) prevents the binding of antigenic
peptides to the class II binding groove. In acidic vesicular com-
partments Ii is cleaved and antigenic peptides can bind to MHC
class II heterodimers with the help of chaperones. In contrast to
MHC-I presentation, the role of autophagy in MHC-II presenta-
tion is more clear. Thus, it could be shown by several groups that
macroautophagy and chaperone-mediated autopahgy play major
roles in promoting presentation of peptides derived fromcytoplas-
mic and nuclear proteins on MHC-II (Nimmerjahn et al., 2003;
Dengjel et al., 2005; Zhou et al., 2005). This is also true for the pre-
sentation of some virus derived peptides, like from Epstein Barr
virus nuclear antigen 1 (Paludan et al., 2005) and from inﬂuenza
virus matrix protein (Schmid et al., 2007). Interestingly, for MHC
class I as well as for MHC class II presentation a dual dependency
on proteasome- and autophagy-activity could be observed high-
lighting a crosstalk between the two degradation pathways (Dörfel
et al., 2005; English et al., 2009).Along this line,we could show that
the proteasome is one of the “favorite substrates” of autophago-
somes and that proteasome activity is modulated by functional
autophagy (Dengjel et al., 2012). However, the exact molecular
mechanisms underlying autophagy–proteasome crosstalk are still
not fully unveiled andmorework has to be done. E.g., it is not clear
if proteasomes are active inside autophagosomes and if autophago-
somes may thus be regarded as scaffolds bringing together the
proteasome with its substrates.
INFLUENZA VIRUS VERSUS AUTOPHAGY. WHO TAKES
CONTROL?
Many pathogens compromise peptide presentation on MHC mol-
ecules by blocking the inductionof autophagyor thematurationof
autophagosomes. Moreover, it is known that some viruses induce
autophagy but inhibit autophagosome–lysosome fusion (Deretic
and Levine, 2009). Hence, several viruses inhibit autophagy at
the level of autophagosome initiation by antagonizing Beclin-1.
Examples of them are the α-herpervirus (HSV-1; Orvedahl et al.,
2007), and γ-herpesviruses, which include human pathogens such
as Epstein Barr virus, Kaposi’s sarcoma associated herpesvirus
(KSHV) and murine γ-HV68 (Liang et al., 2008). In contrast
to DNA viruses, RNA viruses, including HIV (Kyei et al., 2009;
Blanchet et al., 2010), hepatitis C (Ait-Goughoulte et al., 2008;
Dreux et al., 2009), and poliovirus (Dales et al., 1965; Jackson et al.,
2005), block autophagosome maturation and consequently degra-
dation, possibly to beneﬁt from vesicular organelles for their repli-
cation (Rossman and Lamb, 2009; Münz, 2011a). Non-maturing
autophagosomes offer a propitious environment for virus replica-
tion, due to the fact that high concentrations of viral proteins can
be accumulated while being unnoticed by the adaptive immune
system (Rossman and Lamb, 2009). Importantly, viruses inhibit-
ing autophagosome maturation target Beclin-1 as well, as it is also
involved in the maturation process as binding partner of UVRAG.
Although it is well accepted that inﬂuenza virus infection
affects autophagy, controversy still remains in many aspects of
the underlying mechanisms and functional strategies employed
by the virus to succeed in its infective purpose. Various indepen-
dent studies suggest that an increasingly sophisticated connection
exists between autophagy, apoptosis and viral replication. More-
over, interconnection between these three processes appears to
be cell-line dependent, further complicating interpretation of the
gathered data on the effects of inﬂuenza virus infection.
Autophagy is induced by reactive oxygen species (Huang et al.,
2011) which are also produced after inﬂuenza infection (Vlahos
et al., 2012) highlighting a potential point of crosstalk. Oxidiz-
ing molecules are suggested to modulate ATG4 activity leading to
LC3-II accumulation (Scherz-Shouval et al., 2007). Inﬂuenza virus
has been also proposed to up-regulate the expression of ATG7,
ATG5, and ATG12 (Dai et al., 2012). Hence, all of these actions
lead to autophagosome accumulation and may be tracked back
to inﬂuenza virus infection. Signiﬁcantly, it has been suggested
that autophagy is involved in virus-dependent cytokine induc-
tion, which is thought to be the main cause of death of infected
patients (Law et al., 2010).
A closer look at the association between inﬂuenza virus infec-
tion and autophagy raises many questions. It is well documented
that inﬂuenza virus inhibits autophagy at the stage of autophago-
some fusion with lysosomes, and thus leads to an accumulation
of autophagosomes in human lung carcinoma-derived cells (Gan-
nagé et al., 2009). On the other hand, it was shown that different
strains of inﬂuenza virus induce functional autophagy, as detected
by degradation of the autophagy receptor p62 in infected pri-
mary human blood macrophages (Law et al., 2010). A third report
stated as well that inﬂuenza virus infection does induce func-
tional autophagy in several different cell lines, with no detectable
block in the pathway, as concluded from both GFP-LC3 and p62
degradation measurements (Comber et al., 2011). In an attempt
to conciliate all apparently contradicting results, the authors of
the latter work suggested that discrepancies may be due to the
cell types or the inﬂuenza virus strains used for the experiments
(Comber et al., 2011).
Another polemic aspect is the functional association between
autophagy and viral replication. The purpose of compromising a
key homeostatic pathway of the cell by inﬂuenza virus is still under
debate. It was observed that inﬂuenza virus infection decreases
cell survival by inducing apoptosis and inhibiting autophagy. The
induction of apoptosis was suggested to circumvent an anti-viral
immune response (Gannagé et al., 2009). However, autophagy had
apparently a negligible inﬂuence on viral yields, given that loss of
the degradation process did not affect virus replication. There-
fore it was concluded that viral replication does not require the
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autophagosome environment to take its course (Gannagé et al.,
2009). Hence, it has been suggested that inﬂuenza virus seems
to remain in the cytoplasm and nucleus for its replication (Ross-
man and Lamb, 2009). But why does inﬂuenza virus compromise
autophagy? In contrast to the mentioned study, another investi-
gation showed that inhibition of autophagy reduces replication of
inﬂuenza virus (Zhou et al., 2009). On top, it was suggested that
inﬂuenza virus induces autophagy only when apoptosis is ﬁrst
inhibited (McLean et al., 2009). This evidence was proposed to
be the reason for the apparently opposing results attained before
(Rossman and Lamb, 2009).
On the molecular level, there is solid evidence that binding of
inﬂuenza virus M2 protein to Beclin-1 compromises autophagy at
the step of lysosome fusion to autophagosomes (Gannagé et al.,
2009). Beclin-1 contains a conserved BH3 domain (Oberstein
et al., 2007). Such domains were ﬁrst discovered in the context of
apoptosis,but then could also be related to regulationof autophagy
(Sinha and Levine, 2008). Figures 5A,B show the amphipathic
BH3 helix of Beclin-1 interacting with a conserved hydrophobic
groove of Bcl-XL and M11, respectively. Bcl-XL belongs to the Bcl-
2 family of proteins, known to regulate apoptotic and autophagic
processes in the cell (Sinha and Levine, 2008). M11 is a Bcl-2
homolog present in the human pathogen γ-herpesvirus 68, able to
regulate autophagy through interaction with Beclin-1 (Sinha et al.,
2008).
It could be shown that inﬂuenza virus M2 integral mem-
brane protein is necessary and sufﬁcient to block autophagosome–
lysosome fusion (Gannagé et al., 2009). Transient expression of
inﬂuenza A virus M2 protein reproduced the same phenotype
as viral infection, i.e., autophagosomes accumulation due to a
FIGURE 5 | Crystallographic structure of the BH3 helix of Beclin-1,
shown in yellow, complexed to (A) Bcl-XL (PDB code 2p1l) and (B) M11
(PDB code 3bl2). (C) Crystallographic structure of M2 transmembrane
protein from inﬂuenza virus (PDB code 2kih); residues 23–49 including the
transmembrane domain are shown in green and the cytoplasmic helices
(residues 50–60) in blue. (D) Superimposition of Beclin-1 complexed to
Bcl-XL and inﬂuenza virus M2 protein. The picture was prepared using the
program VMD (Humphrey et al., 1996), and MultiProt Server was employed
for protein alignment (Shatsky et al., 2004).
block in autophagosome maturation and not to an increase in
autophagy. Silencing M2 expression during inﬂuenza A virus
infection, or infecting cells with a M2 knockout inﬂuenza A
virus, reverted the phenotype of classical infection, allowing
autophagosome–lysosome fusion (Gannagé et al., 2009, 2010). M2
is a proton-selective ion channel responsible for acidiﬁcation of
the viral core once the virus reaches endosomes, causing disso-
ciation of the viral particles and release of the genome into the
cytoplasm (Wang et al., 2011). Surprisingly, it has been observed
that autophagosome maturation is not inhibited by the M2 ion
channel activity itself and that the ﬁrst 60 residues of the protein
are sufﬁcient to inhibit autophagy by binding to Beclin-1 (Gan-
nagé et al., 2009, 2010). The precise mechanism of inhibition has
not been clearly determined, but it has been proposed that M2
is likely to interact with Beclin-1 through either the ectodomain
(residues 1-24) or the cytoplasmic amphipatic helix (residues 46–
62), but not through the transmembrane domain which should be
shielded from access (Rossman and Lamb, 2009).
As shown in Figure 5, the secondary structures of both Bcl-XL
and M11 contain mostly α-helices, as do the ﬁrst 70 amino acid-
residues of inﬂuenza virus M2 protein,which are needed to inhibit
Beclin-1. If crystallographic structures of the complex Beclin-1–
Bcl-XL and M2 are aligned, one of the transmembrane α-helices
of M2 superimposes with one of the α-helices of Bcl-XL which
interacts with Beclin-1 (Figures 5C,D). In our opinion, it cannot
be excluded that this ion channel transmembrane domain of M2
binds to Beclin-1. This may happen before the M2 homotetramer
complex is fully assembled in the membrane indicating a second,
non-membrane-bound, function/role of this protein and possibly
explaining the observation that the M2 ion channel activity seems
not to be involved in its functions in autophagy regulation. To
fully understand the modulations of autophagy by inﬂuenza virus
and to outline the underlying molecular mechanisms more work
has to be done, e.g., speciﬁcally addressing protein dynamics and
protein–protein interactions under various conditions.
CONCLUSION
Autophagy is a highly complex process and only the identiﬁcation
of autophagy-related genes in the genetically tractable organism
yeast and the fact that the process is conserved in humans have
allowed the elucidationof underlyingmolecularmechanisms lead-
ing to the generation of autophagosomes in mammalian cells.
Although we have gained a tremendous amount of knowledge in
the last decade there are still many unanswered questions, espe-
cially related to human diseases. Viruses employ autophagy for
their own goods and the studying of autophagy modulation by
viral infection and viral proteins will allow a deeper insight into
underlying molecular mechanisms shedding more light onto this
basal cell biological process. We are conﬁdent that the newly gen-
erated knowledge will not only allow the design of new anti-viral
therapies but will also help in targeting autophagy in other disease
settings.
Regarding macroautophagy, a lot of work has to be done to
fully understand target selection. Can a cell actually allow a com-
pletely unspeciﬁc bulk degradation process to happen? Large-scale
“omics” approaches should help in generating enough data to
comprehensively tackle this problem on a global scale.
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